Allergic rhinitis drug delivery implant
US11590329B2 · kind B2 · utility
0Cited by
4References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2019 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Oct 9, 2039 |
Classification
- Technology area (CPC D)Textiles; Paper
- CPC primaryD06M16/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In another example, a bioresorbable implant for use in a nasal region includes one or more bioresorbable polymers, and a pharmaceutical composition coupled to the one or more bioresorbable polymers. A release rate of the pharmaceutical composition is related to a degradation rate of the one or more bioresorbable polymers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.